BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29775084)

  • 1. Health state utilities in patients with advanced non-small-cell lung cancer in China.
    Shen Y; Wu B; Wang X; Zhu J
    J Comp Eff Res; 2018 May; 7(5):443-452. PubMed ID: 29775084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life and utility in patients with advanced non-small-cell lung cancer: a prospective cross-sectional patient survey in a real-world setting.
    Chouaid C; Agulnik J; Goker E; Herder GJ; Lester JF; Vansteenkiste J; Finnern HW; Lungershausen J; Eriksson J; Kim K; Mitchell PL
    J Thorac Oncol; 2013 Aug; 8(8):997-1003. PubMed ID: 23787802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life and utility in patients with non-small cell lung cancer. Quality-of-life Study Group of the Master 2 Project in Pharmacoeconomics.
    Trippoli S; Vaiani M; Lucioni C; Messori A
    Pharmacoeconomics; 2001; 19(8):855-63. PubMed ID: 11596837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The humanistic burden of advanced non-small cell lung cancer (NSCLC) in Europe: a real-world survey linking patient clinical factors to patient and caregiver burden.
    Wood R; Taylor-Stokes G; Smith F; Chaib C
    Qual Life Res; 2019 Jul; 28(7):1849-1861. PubMed ID: 30825160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does caring for patients with advanced non-small cell lung cancer affect health-related quality of life of caregivers? A multicenter, cross-sectional study.
    Yang Y; Liu L; Chen J; Gan Y; Su C; Zhang H; Long E; Yan F; Chen Y
    BMC Public Health; 2024 Jan; 24(1):224. PubMed ID: 38238722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health state utilities in non-small cell lung cancer: An international study.
    Nafees B; Lloyd AJ; Dewilde S; Rajan N; Lorenzo M
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e195-e203. PubMed ID: 26990789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The humanistic burden associated with caring for patients with advanced non-small cell lung cancer (NSCLC) in three European countries-a real-world survey of caregivers.
    Wood R; Taylor-Stokes G; Lees M
    Support Care Cancer; 2019 May; 27(5):1709-1719. PubMed ID: 30121787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in patients surviving non-small cell lung cancer.
    Grutters JP; Joore MA; Wiegman EM; Langendijk JA; de Ruysscher D; Hochstenbag M; Botterweck A; Lambin P; Pijls-Johannesma M
    Thorax; 2010 Oct; 65(10):903-7. PubMed ID: 20861294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life and utility scores of patients with breast neoplasms in China: A multicenter cross-sectional survey.
    Wang L; Shi JF; Zhu J; Huang HY; Bai YN; Liu GX; Liao XZ; Mao AY; Ren JS; Sun XJ; Guo LW; Fang Y; Zhou Q; Ma HM; Xing XJ; Zhu L; Song BB; Du LB; Mai L; Liu YQ; Ren Y; Lan L; Zhou JY; Qi X; Sun XH; Lou PA; Wu SL; Li N; Zhang K; He J; Dai M;
    Breast; 2018 Jun; 39():53-62. PubMed ID: 29597131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients.
    Paracha N; Abdulla A; MacGilchrist KS
    Health Qual Life Outcomes; 2018 Sep; 16(1):179. PubMed ID: 30208899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health state utility scores in advanced non-small cell lung cancer.
    Doyle S; Lloyd A; Walker M
    Lung Cancer; 2008 Dec; 62(3):374-80. PubMed ID: 18467000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
    McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
    Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life of patients with colorectal neoplasms in China: A multicenter cross-sectional survey.
    Huang HY; Wang H; Shi JF; Bai YN; Wang L; Liu CC; Yan XX; Liu GX; Liao XZ; Shi D; Mao AY; Ren JS; Sun XJ; Guan HJ; Huang WD; Lei HK; Gong JY; Liu YY; Zhu L; Song BB; Du LB; Guo LW; Liu YQ; Ren Y; Lan L; Zhou JY; Qi X; Sun XH; Lou PA; Wu SL; Tang Y; Li N; Zhang K; Li N; Chen WQ; Dai M; He J
    J Gastroenterol Hepatol; 2021 May; 36(5):1197-1207. PubMed ID: 32875595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.
    Chen G; Garcia-Gordillo MA; Collado-Mateo D; Del Pozo-Cruz B; Adsuar JC; Cordero-Ferrera JM; Abellán-Perpiñán JM; Sánchez-Martínez FI
    Patient; 2018 Dec; 11(6):665-675. PubMed ID: 29876865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility values associated with advanced or metastatic non-small cell lung cancer: data needs for economic modeling.
    Brown J; Cook K; Adamski K; Lau J; Bargo D; Breen S; Chawla A
    Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):153-164. PubMed ID: 28335636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
    Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of health-related quality of life and symptoms in patients with advanced non-squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 057.
    Reck M; Brahmer J; Bennett B; Taylor F; Penrod JR; DeRosa M; Dastani H; Spigel DR; Gralla RJ
    Eur J Cancer; 2018 Oct; 102():23-30. PubMed ID: 30103096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of FACT- and EQ-5D-based utility scores in cancer.
    Pickard AS; Ray S; Ganguli A; Cella D
    Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping AcroQoL scores to EQ-5D to obtain utility values for patients with acromegaly.
    Badia X; Trainer P; Biermasz NR; Tiemensma J; Carreño A; Roset M; Forsythe A; Webb SM
    J Med Econ; 2018 Apr; 21(4):382-389. PubMed ID: 29261359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany.
    Iyer S; Taylor-Stokes G; Roughley A
    Lung Cancer; 2013 Aug; 81(2):288-93. PubMed ID: 23561304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.